[Skip to Content]
[Skip to Content Landing]
June 28, 2010

Cholesterol-Lowering Therapy for Primary PreventionStill Much We Don't Know

Author Affiliations

Author Affiliation: Department of Family Medicine, University of Michigan Medical School, Ann Arbor.

Arch Intern Med. 2010;170(12):1007-1008. doi:10.1001/archinternmed.2010.168

In this issue of the Archives, Ray et al1 and de Lorgeril et al2 reignite the long-simmering controversy concerning the use of lipid-lowering therapy for the primary prevention of cardiovascular and cerebrovascular events. Each article provides a different and valuable perspective.

First Page Preview View Large
First page PDF preview
First page PDF preview